GraniteShares YieldBOOST Biotech ETF (BIOY)
NASDAQ: BIOYGranitesharesDerivative IncomeETFUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BIOY chart
Full chartKey facts
- Expense ratio
- 1.07%
- Assets (AUM)
- $1.23M
- Dividend yield
- 1.16%
- Holdings
- —
- Inception
- May 4, 2026
- Issuer
- Graniteshares
- Index tracked
- —
- Category
- Derivative Income
- 52-week range
- 19.76 – 25.28
- Volume / Avg
- 779 / 2.20K
- Beta
- —
- Previous close
- 19.73
BIOY ETF today
The GraniteShares YieldBOOST Biotech ETF (BIOY) is an exchange-traded fund from Graniteshares in the Derivative Income category. It charges an expense ratio of 1.07%, or $107.00 per year on a $10,000 investment, and manages $1.2 million in assets. The fund's trailing dividend yield is 1.16%.
BIOY launched on May 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
BIOY performance
1 week
+0.50%
BIOY price return, excluding dividends.
ETFs similar to BIOY
BIOY ETF FAQ
What is the BIOY price today?
BIOY last traded at $20.12 as of Oct 9, 4:00 PM EDT, up 1.97% on the day.
What is BIOY's expense ratio?
BIOY has an expense ratio of 1.07%, which works out to about $107.00 per year for every $10,000 invested.
Does BIOY pay a dividend?
Yes. BIOY has a trailing dividend yield of 1.16% and pays distributions; the most recent was $0.2332 per share with an ex-dividend date of Oct 9, 2026.
How big is BIOY?
BIOY has about $1.2 million in assets under management.